
5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines
M. Campone, N. Dobrovolskaya, S. Tjulandin, S.C. Chen, S.J. Fourié, F. Mefti, M. Konstantinova, J.C. Pouget, F. Lefresne, J. JassemVolume:
7
Année:
2009
Langue:
english
DOI:
10.1016/s1359-6349(09)70892-4
Fichier:
PDF, 47 KB
english, 2009